Actimed Therapeutics Announces Successful Closing of £2.5m Extended Seed B Funding Round

By In The News
June 10, 2021 in The Headlines

Recommended Posts

In The News

Posted June 10, 2021

- Share

Posted June 10, 2021

LONDON, June 10, 2021 /PRNewswire/ -- Actimed Therapeutics Ltd, the clinical stage company focused on bringing innovation to the treatment of muscle wasting disorders, with a focus on cachexia, today announces the successful closing of its extended Seed B financing round which was...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  221806
2. Jaydee
  17647
3. deicer
  13207
4. Kip Powick
  12292
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.2k
- Total Posts
  
  564.3k

Sign In

Actimed Therapeutics Announces Successful Closing of £2.5m Extended Seed B Funding Round

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support